resorcinol has been researched along with benzamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arndt, JW; Biamonte, MA; Lee, WC; Perret, D; Scannevin, RH; Van de Water, R | 1 |
| Ha, E; Jeong, JH; Kim, SH; Lho, Y; Liu, KH; Oh, YJ; Park, SY; Seo, YH; Song, J | 1 |
2 other study(ies) available for resorcinol and benzamide
| Article | Year |
|---|---|
Heat shock protein 90: inhibitors in clinical trials.
Topics: Animals; Benzamides; Benzoquinones; Clinical Trials as Topic; Drug Design; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Molecular Structure; Purines; Resorcinols; Structure-Activity Relationship | 2010 |
Design, synthesis, and biological evaluation of a series of resorcinol-based N-benzyl benzamide derivatives as potent Hsp90 inhibitors.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Male; Mice, Inbred NOD; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Resorcinols; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |